{
  "id": 4659131,
  "title": "ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy",
  "url": "https://urgent.news/2026/08/31/esc-26-cytokinetics-sell-off-arrowheads-edge-and-a-heart-drug-autopsy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T14:49:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/esc-congress-2026-results-eplontersen-alnylam-cytokinetics/829139/"
  },
  "original_language": "en",
  "account": null,
  "summary": "At a big meeting for cardiovascular medicines, Cytokinetics and Arrowhead aimed to separate their drugs from competitors while a failed study pressured Alnylam.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "#ESC26: Arrowhead claims safety edge over Ionis as triglyceride battle draws closer",
        "url": "https://urgent.news/2026/08/30/esc26-arrowhead-claims-safety-edge-over-ionis-as-triglyceride-battle",
        "published": "2026-08-30T15:40:30.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}